PrimeVigilance is pleased to announce that both Dr. Michael Forstner (PrimeVigilance Senior VP – Head of Risk Management and Pharmacoepidemiology) and Dr Jan Petracek (PrimeVigilance CEO, and former Head of Risk Management at EMA) were selected expert speakers during the upcoming DIA Pharmacovigilance and Risk Management Strategies Conference held this January 28-30, 2019 in Washington, DC.
On Monday 28th January, Dr. Petracek will be on the panel for Session 5: Pharmacovigilance and Risk Management Challenges in Advanced Therapeutics, with his topic being “Benefit-Risk Management of Recently Authorized ATMPs in the EU – Lessons Learned”.
On Tuesday 29th January, Session 8, Dr. Forstner will deliver a focused presentation “The European IV Iron PASS Consortium: Experiences from coordinating a multi-company, multi-registry PASS”.
DIA’s Pharmacovigilance and Risk Management Strategies Conference provides the context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies.
Program and registration details are available on the #DIAwebsite here.
If you would like to set up a meeting with us during this event or have any other questions, please let us know by contacting us directly at firstname.lastname@example.org.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)